citalopram + fluoxetine + fluvoxamine + paroxetine + sertraline

This is a combination of five selective serotonin reuptake inhibitors (SSRIs): citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline. Each of these drugs individually acts as an SSRI by inhibiting the reuptake of serotonin in the brain, thereby increasing its availability in the synaptic cleft and enhancing serotonergic neurotransmission. SSRIs are primarily used to treat depression and various anxiety disorders. While combining different SSRIs is not standard clinical practice due to increased risk of adverse effects such as serotonin syndrome—a potentially life-threatening condition caused by excessive serotonergic activity—there are rare case reports or experimental uses where two SSRIs have been combined for treatment-resistant cases under close supervision[6][10]. However, there is no evidence or approval for using all five together as a single therapy; such a combination would carry significant risks including severe drug interactions and heightened side effect profiles[6][8].